查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球心臟內超音波(ICE) 市場：市場規模、佔有率、趨勢 - 按產品、按應用、按最終用戶、按地區 - 預測到 2029 年
市場調查報告書
商品編碼
1537100

全球心臟內超音波(ICE) 市場：市場規模、佔有率、趨勢 - 按產品、按應用、按最終用戶、按地區 - 預測到 2029 年

Intracardiac Echocardiography Market / ICE Market Size, Share & Trends by Product (Ultrasound, Catheter, Console, Software), Application, End user & Region Global Forecasts to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 299 Pages | 訂單完成後即時交付

價格

全球心臟內超音波(ICE) 市場規模預計將從 2024 年的 3.33 億美元增加到 2029 年的 5.45 億美元，預測期內複合年成長率為 10.3%。

優勢融合將支持心臟內超音波(ICE) 市場的預期成長。預計的心臟內超音波(ICE) 市場擴張是由人口老化趨勢、診斷技術的持續進步以及先進成像工具的更多採用所推動的，這些工具提供心臟結構和血流的即時高解析度成像。這些因素協同促進了預測期內 ICE 市場的成長前景。

調查範圍
調查年份 2022-2029
基準年 2023年
預測期 2024-2029
考慮單位 金額（百萬美元）
部分 按產品、按應用、按最終用戶、按地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東/非洲

2024 年至 2029 年的預測顯示，ICE超音波系統領域將擁有最大的市場佔有率。超音波換能器技術和導管設計的進步，以及透過與其他成像工具整合的全面可視化和導航，推動了心臟超音波圖超音波系統的興起。消費者對微創手術的需求、軟體應用的改進以及冠狀動脈疾病的增加正在促進 ICE超音波設備的擴展和採用。

以應用來看，2023年電生理學領域佔據心臟內超音波（ICE）市場的最大佔有率。即時視覺化功能、改進的手術安全性和準確性以及長期監測心臟健康以早期發現疾病是推動心內超音波心動圖電生理學市場成長的關鍵因素。

醫院和外科中心：2023 年，診斷領域在全球心臟內超音波(ICE) 市場中佔據最大佔有率。醫院和外科中心：診斷技術的不斷進步、消費者對優質診斷服務的需求不斷增加、有利的法規環境和現代診斷工具的更多採用所推動的診斷能力的擴大推動了診斷領域的成長。

本報告研究了全球心臟內超音波(ICE) 市場，並按產品、應用、最終用戶、地區和參與市場的公司概況總結了趨勢。

目錄

第1章 簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態
  • 波特五力分析
  • 監管分析
  • 退款場景
  • 生態系分析
  • 投資金籌措場景
  • 技術分析
  • 價值鏈分析
  • 供應鏈分析
  • 價格分析
  • 專利分析
  • 貿易分析
  • 2024-2025年重大會議和活動
  • 影響客戶業務的趨勢/干擾
  • 主要相關人員和採購標準
  • 鄰近市場分析
  • 未滿足的需求和主要問題
  • 心臟內超音波(ICE) 測試中的人工智慧

第6章心臟內超音波(ICE) 市場，依產品

  • 介紹
  • 內建軟體的 ICE超音波系統
  • ICE導管
  • ICE主機
  • 引導管和鞘套
  • 免洗配件
  • 軟體

第7章心臟內超音波（ICE）市場，依應用

  • 介紹
  • 結構性心臟缺陷
  • 電生理學
  • 左心耳封堵術
  • 心臟監測
  • 其他

第 8 章心臟內超音波(ICE) 市場（依最終用戶）

  • 介紹
  • 醫院和外科中心
  • 門診手術中心
  • 醫院導管實驗室/混合或介入中心
  • 獨立診斷中心
  • 其他

第9章心臟內超音波（ICE）市場（按地區）

  • 介紹
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第10章競爭格局

  • 介紹
  • 主要參與企業的策略/秘密
  • 收益分析
  • 市場佔有率分析
  • 企業評估矩陣：主要參與企業，2023
  • 企業評估矩陣：Start-Ups/小型企業，2023 年
  • 企業價值評估及財務指標
  • 產品/品牌比較
  • 競爭場景

第11章 公司簡介

  • 主要參與企業
    • MEDTRONIC
    • ABBOTT
    • SIEMENS HEALTHINEERS AG
    • GE HEALTHCARE
    • BOSTON SCIENTIFIC CORPORATION
    • PHILIPS HEALTHCARE
    • JOHNSON & JOHNSON MEDTECH
    • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • EDWARDS LIFESCIENCES CORPORATION
    • CANON MEDICAL SYSTEMS CORPORATION
    • FUJIFILM HOLDINGS CORPORATION
    • GUERBET
    • TERUMO CORPORATION
    • LIVANOVA
    • INFRAREDX INC.
    • STEREOTAXIS, INC.
    • B. BRAUN SE
    • ESAOTE SPA
  • 其他公司
    • CHISON MEDICAL TECHNOLOGIES CO., LTD.
    • SHIFAMED, LLC
    • CONAVI MEDICAL INC.
    • XUZHOU KAIXIN ELECTRONIC INSTRUMENT CO., LTD.
    • BK MEDICAL
    • BENQ MEDICAL TECHNOLOGY
    • ECHONOUS INC.
    • VOLTA MEDICAL
    • TRIVITRON HEALTHCARE
    • ECHOPIXEL
    • CATHVISION
    • PIE MEDICAL IMAGING BV

第12章附錄

Product Code: AST 9119

The global intracardiac echocardiography (ICE) market is projected to reach USD 545 million by 2029 from USD 333 million in 2024, growing at a CAGR of 10.3% during the forecast period. The projected market growth for intracardiac echocardiography (ICE) is supported by the convergence of benefits. The projected expansion of the intracardiac echocardiography (ICE) market is driven by demographic trends favoring an aging population, continuous advancements in diagnostic technologies, increased adoption of advanced imaging tools, and the capability to deliver real-time, high-resolution imaging of cardiac structures and blood flow. These factors synergistically contribute to the growth prospects of the ICE market in the forecasted period.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million)
SegmentsProduct, Application, End User and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa

" ICE Ultrasound Systems with Inbuild Software Applications segment to register largest market share in 2023-2029."

Based on the product, the intracardiac echocardiography (ICE) market is segmented into ICE Ultrasound Systems with Inbuild Software Applications (2D ultrasound systems, 3D/4D ultrasound systems, doppler ultrasound systems), ICE Catheters (Dopper ICE catheters, phased - array ICE catheters, fixed - array ICE catheters, mechanical rotational ICE catheters) , ICE Consoles (cart/ trolley-based consoles, hand-held/ portable consoles), guiding catheters and sheaths, disposable accessories, and softwares are used in intracardiac echocardiography (ICE) taken into account while estimating the entire market. The ICE Ultrasound Systems segment registered the largest market share for the forecasted year of 2024-2029. Developments in ultrasound transducer technology and catheter designs, as well as its integration with other imaging tools to give comprehensive visualisation and navigation, are responsible for the emergence of intracardiac echocardiography ultrasound systems. Consumer demand for minimally invasive procedures, improved software applications, and an increase in the rate of coronary diseases are all contributing to the expansion and widespread use of ICE ultrasound devices.

"Electrophysiolgy segment held the largest share of intracardiac echocardiography (ICE) market in 2023, by application."

Based on the application, the intracardiac echocardiography (ICE) market is segmented into electrophysiology, structural heart defects (mitral valve repair/ replacement, aortic valve replacement and other heart defects), cardiac monitoring, left atrial appendage closure, and other applications. In 2023, the electrophysiolgy segment accounted the largest share of global intracardiac echocardiography (ICE) market. Real-time visualization capabilities, improved safety and accuracy in procedures, and the ability to monitor cardiac health over extended periods for early disease detection are pivotal drivers propelling growth in the electrophysiology in intracardia echocardiography market.

"hospitals & surgical centers: diagnostic segment held the largest share of intracardiac echocardiography (ICE) market in 2023, by End-user."

Based on the end-user, the intracardiac echocardiography (ICE) market is segmented into Hospital-based cathlabs/ hybrid or interventional, hospitals & surgical centers: diagnostic, Ambulatory surgical centers (ASCs) and independent diagnostic centers and Other end users. In 2023, the hospitals & surgical centers: diagnostic segment had the largest share of the global intracardiac echocardiography (ICE) market. The growth within hospital and surgical centers:diagnostic segment is propelled by continuous advancements in diagnostic technology, escalating consumer demand for superior diagnostic services, and facilitated expansion of diagnostic capabilities due to favorable regulatory environments and increased adoption of modern diagnostic tools.

"Asia Pacific to register significant growth rate in the market during the forecast period."

For the forecasting period 2024-2029, The Asia-Pacific (APAC) region is anticipated to experience substantial growth throughout the forecast period. Asia Pacific comprises Japan, India, China, South Korea, Australia, and RoAPAC. The Asia-Pacific (APAC) region has experienced a notable acceleration in the market growth rate for intracardiac echocardiography (ICE). Several factors have contributed to the growth of the intracardiac echocardiography (ICE) market in the APAC region. Continuous innovations in ultrasound technology are driving this expansion. Additionally, governments in the Asia Pacific are making significant investments in healthcare infrastructure and advanced medical technologies. The rising incidence of cardiovascular diseases in the region further increases the demand for advanced diagnostic and imaging technologies like ICE, aiming to enhance patient care and outcomes.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
  • By Designation: C-level-- 27%, Director-level-18%, and Others-55%
  • By Region: North America-50%, Europe-20%, Asia Pacific-15%, Latin America-10%, and the Middle East & Africa-5%

Prominent players in this market are Johnson & Johson Medtech (US), Medtronic (Ireland), Abbott Laboratories (US), Siemens Healthineers (Germany), Philips healthcare (Netherland) among others.

Research Coverage

  • The report studies the intracardiac echocardiography (ICE) market based on products, application, end user, and region.
  • The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
  • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
  • The report studies micro markets with respect to their growth trends, prospects, and contributions to the global intracardiac echocardiography (ICE) market.
  • The report forecasts the revenue of market segments with respect to five major regions.

Key Benefits of Buying the Report:

The report will help the new entrants/ market leaders/smaller firms in this market with investment evaluation viability within the intracardiac echocardiography (ICE) market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, challenges, growth catalysts and prospects, thereby empowering strategic decision-making with astute discernment.

The report provides insights on the following pointers:

  • Analysis of key drivers (increasing cardiac issues in overall population, collaboration of other imaging techniques and AI with intracardiac echocardiography technology), restraints (The availability of trained personnel is inconsistent. Additionally, ICE procedures involve significant risks of complications), opportunities (scope of clinical applications for intracardiac echocardiography (ICE) in structural heart disease interventions is expanding), and challenges (incur cost barrier) influencing the growth of the intracardiac echocardiography (ICE) market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the intracardiac echocardiography (ICE) market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the intracardiac echocardiography (ICE) market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the intracardiac echocardiography (ICE) market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Medtronic (Ireland), GE Healthcare (US), Abbott Laboratories (US), Siemens Healthineers (Germany), among others.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 INCLUSIONS & EXCLUSIONS
  • 1.4 MARKET SCOPE
    • 1.4.1 MARKETS COVERED
  • 1.5 YEARS CONSIDERED
  • 1.6 CURRENCY CONSIDERED
  • 1.7 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH DESIGN
    • 2.2.1 SECONDARY RESEARCH
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY RESEARCH
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key industry insights
      • 2.2.2.3 Breakdown of primaries
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation approach
      • 2.3.1.2 Approach 2: Customer-based market estimation
      • 2.3.1.3 Approach 3: Top-down approach
      • 2.3.1.4 Approach 4: Primary interviews
  • 2.4 DATA TRIANGULATION & MARKET BREAKDOWN
  • 2.5 MARKET SHARE ASSESSMENT
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 ASSUMPTIONS
  • 2.8 RISK ASSESSMENT
  • 2.9 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET OVERVIEW
  • 4.2 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
  • 4.3 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION AND END USER, 2023 (USD MILLION)
  • 4.4 GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Emergence of predictive analytics in ICE technology
      • 5.2.1.2 Expanding clinical use cases of ICE technology
      • 5.2.1.3 Ongoing integration of ICE technology with other imaging modalities
      • 5.2.1.4 Rising prevalence of cardiac disorders
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Premium product pricing
      • 5.2.2.2 Dearth of healthcare professionals
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Broadening clinical applications of ICE in structural heart disease interventions
      • 5.2.3.2 Advances in 3D and real-time 3D (4D) imaging
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Technical limitations
      • 5.2.4.2 Increased pricing pressure on market players
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF SUPPLIERS
    • 5.3.4 BARGAINING POWER OF BUYERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 REGULATORY ANALYSIS
    • 5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.4.2 KEY REGULATORY GUIDELINES
      • 5.4.2.1 North America
        • 5.4.2.1.1 US
        • 5.4.2.1.2 Canada
      • 5.4.2.2 Europe
      • 5.4.2.3 Asia Pacific
        • 5.4.2.3.1 Japan
        • 5.4.2.3.2 India
        • 5.4.2.3.3 China
  • 5.5 REIMBURSEMENT SCENARIO
  • 5.6 ECOSYSTEM ANALYSIS
  • 5.7 INVESTMENT & FUNDING SCENARIO
  • 5.8 TECHNOLOGY ANALYSIS
    • 5.8.1 KEY TECHNOLOGIES
      • 5.8.1.1 Phased-array ICE
      • 5.8.1.2 Rotational ICE
      • 5.8.1.3 Doppler imaging
      • 5.8.1.4 3D ICE technology
    • 5.8.2 COMPLEMENTARY TECHNOLOGIES
      • 5.8.2.1 Intravascular ultrasound (IVUS)
      • 5.8.2.2 Value-added software (AI and IoT)
      • 5.8.2.3 Clinical decision support systems
      • 5.8.2.4 Electrophysiology (EP) mapping systems
    • 5.8.3 ADJACENT TECHNOLOGIES
      • 5.8.3.1 Event monitors
      • 5.8.3.2 Holter monitors
  • 5.9 VALUE CHAIN ANALYSIS
    • 5.9.1 RESEARCH & DEVELOPMENT
    • 5.9.2 PROCUREMENT AND PRODUCT DEVELOPMENT
    • 5.9.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
  • 5.10 SUPPLY CHAIN ANALYSIS
    • 5.10.1 PROMINENT COMPANIES
    • 5.10.2 SMALL & MEDIUM-SIZED ENTERPRISES
    • 5.10.3 END USERS
  • 5.11 PRICING ANALYSIS
  • 5.12 PATENT ANALYSIS
  • 5.13 TRADE ANALYSIS
  • 5.14 KEY CONFERENCES & EVENTS, 2024-2025
  • 5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.16 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.16.2 BUYING CRITERIA
  • 5.17 ADJACENT MARKET ANALYSIS
  • 5.18 UNMET NEEDS & KEY PAIN POINTS
  • 5.19 ARTIFICIAL INTELLIGENCE IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE)

6 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE
    • 6.2.1 2D ULTRASOUND SYSTEMS
      • 6.2.1.1 Increasing integration of modern ICE systems with other diagnostic systems to drive market growth
    • 6.2.2 3D/4D ULTRASOUND SYSTEMS
      • 6.2.2.1 Increasing incidence of cardiovascular diseases worldwide to drive growth
    • 6.2.3 DOPPLER ULTRASOUND SYSTEMS
      • 6.2.3.1 Higher resolution imaging and advanced Doppler techniques to enhance capability of ICE systems
  • 6.3 ICE CATHETERS
    • 6.3.1 DOPPLER ICE CATHETERS
      • 6.3.1.1 Growing preference for minimally invasive cardiac procedures to support market growth
    • 6.3.2 PHASED-ARRAY ICE CATHETERS
      • 6.3.2.1 High cost and limited applications to restrict market growth
    • 6.3.3 FIXED-ARRAY ICE CATHETERS
      • 6.3.3.1 High demand for advanced cardiac imaging solutions to drive innovation and adoption of fixed-array catheters
    • 6.3.4 MECHANICAL ROTATIONAL ICE CATHETERS
      • 6.3.4.1 Innovations in catheter technology to boost market growth
  • 6.4 ICE CONSOLES
    • 6.4.1 CART/TROLLEY-BASED CONSOLES
      • 6.4.1.1 Rising geriatric population to fuel market growth
    • 6.4.2 HANDHELD/PORTABLE CONSOLES
      • 6.4.2.1 Increasing adoption of portable consoles in healthcare facilities to drive market growth
  • 6.5 GUIDING CATHETERS & SHEATHS
    • 6.5.1 INCREASING INTEGRATION OF GUIDING CATHETERS & SHEATHS WITH PORTABLE ICE CONSOLES TO PROPEL MARKET GROWTH
  • 6.6 DISPOSABLE ACCESSORIES
    • 6.6.1 COST OF DISPOSABLE ACCESSORIES TO PLAY SIGNIFICANT ROLE IN DRIVING MARKET GROWTH
  • 6.7 SOFTWARE
    • 6.7.1 INCREASING ADOPTION OF PREDICTIVE ANALYTICS FOR REAL-TIME IMAGING TO BOOST MARKET

7 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 STRUCTURAL HEART DEFECTS
    • 7.2.1 MITRAL VALVE REPAIR/REPLACEMENT
      • 7.2.1.1 Growing burden of cardiovascular diseases to drive market
    • 7.2.2 AORTIC VALVE REPLACEMENT
      • 7.2.2.1 Growing demand for effective imaging tools like ICE to boost market
    • 7.2.3 OTHER STRUCTURAL HEART DEFECTS
  • 7.3 ELECTROPHYSIOLOGY
    • 7.3.1 GROWING INTEGRATION OF ICE WITH MAPPING SYSTEMS TO DRIVE MARKET GROWTH
  • 7.4 LEFT ATRIAL APPENDAGE CLOSURE
    • 7.4.1 BENEFITS SUCH AS MINIMIZATION OF RADIATION EXPOSURE IN PROCEDURES LIKE LAA CLOSURE TO SUPPORT GROWTH
  • 7.5 CARDIAC MONITORING
    • 7.5.1 BETTER CLINICAL DECISION-MAKING AND IMPROVED PATIENT OUTCOMES TO SUPPORT SEGMENT GROWTH
  • 7.6 OTHER APPLICATIONS

8 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS & SURGICAL CENTERS
    • 8.2.1 ABILITY TO AFFORD HIGH INSTALLATION & MAINTENANCE COSTS OF ICE TECHNOLOGIES TO BOOST MARKET
  • 8.3 AMBULATORY SURGICAL CENTERS
    • 8.3.1 COST-EFFECTIVENESS AND CONVENIENCE OF AMBULATORY SURGICAL CENTERS TO DRIVE GROWTH
  • 8.4 HOSPITAL-BASED CATH LABS/HYBRID OR INTERVENTIONAL CENTERS
    • 8.4.1 GROWING USE OF ICE IN CATH LABS FOR MINIMALLY INVASIVE CARDIAC PROCEDURES TO BOOST MARKET
  • 8.5 INDEPENDENT DIAGNOSTIC CENTERS
    • 8.5.1 SPECIALIZED EXPERTISE AND ADVANCED ICE TECHNOLOGY IN INDEPENDENT DIAGNOSTIC CENTERS TO BOOST GROWTH
  • 8.6 OTHER END USERS

9 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 Growing number of FDA approvals for ICE devices to support market growth
    • 9.2.2 CANADA
      • 9.2.2.1 Growing public-private funding for research to drive market growth
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Rising healthcare expenditure and manufacturer expansion to boost market growth
    • 9.3.2 UK
      • 9.3.2.1 Increasing public & private investments to contribute to market growth
    • 9.3.3 FRANCE
      • 9.3.3.1 Statutory health insurance system to support market growth
    • 9.3.4 ITALY
      • 9.3.4.1 Rising incidence of cardiac diseases to drive adoption of ICE devices
    • 9.3.5 SPAIN
      • 9.3.5.1 Growing number of surgical procedures to drive market growth in Spain
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 JAPAN
      • 9.4.1.1 Large geriatric population and favorable reimbursement scenario to support market growth
    • 9.4.2 CHINA
      • 9.4.2.1 Growing focus of local and international market players to favor market growth
    • 9.4.3 INDIA
      • 9.4.3.1 Increasing government-implemented healthcare initiatives to support market growth
    • 9.4.4 AUSTRALIA
      • 9.4.4.1 R&D tax incentive program to support market growth
    • 9.4.5 SOUTH KOREA
      • 9.4.5.1 Supportive government initiatives to drive market growth
    • 9.4.6 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 BRAZIL
      • 9.5.1.1 Brazil to dominate LATAM market
    • 9.5.2 MEXICO
      • 9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
    • 9.5.3 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 GCC COUNTRIES
      • 9.6.1.1 Developments in healthcare infrastructure and high government expenditure to drive market
    • 9.6.2 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET
  • 10.3 REVENUE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS
    • 10.4.1 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SHARE, BY KEY PLAYER, 2023
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Product footprint
      • 10.5.5.3 Application footprint
      • 10.5.5.4 End-user footprint
      • 10.5.5.5 Region footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPANY BENCHMARKING: STARTUPS/SMES, 2023
  • 10.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 10.8 PRODUCT/BRAND COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT LAUNCHES AND APPROVALS
    • 10.9.2 DEALS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 MEDTRONIC
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Product approvals
        • 11.1.1.3.2 Deals
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Key strengths
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses and competitive threats
    • 11.1.2 ABBOTT
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Product launches and approvals
        • 11.1.2.3.2 Deals
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Key strengths
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses and competitive threats
    • 11.1.3 SIEMENS HEALTHINEERS AG
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Product launches and approvals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Key strengths
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses and competitive threats
    • 11.1.4 GE HEALTHCARE
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Product approvals
        • 11.1.4.3.2 Deals
      • 11.1.4.4 MnM view
        • 11.1.4.4.1 Key strengths
        • 11.1.4.4.2 Strategic choices
        • 11.1.4.4.3 Weaknesses and competitive threats
    • 11.1.5 BOSTON SCIENTIFIC CORPORATION
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Product launches
        • 11.1.5.3.2 Deals
        • 11.1.5.3.3 Expansions
      • 11.1.5.4 MnM view
        • 11.1.5.4.1 Key strengths
        • 11.1.5.4.2 Strategic choices
        • 11.1.5.4.3 Weaknesses and competitive threats
    • 11.1.6 PHILIPS HEALTHCARE
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Product launches and approvals
        • 11.1.6.3.2 Deals
        • 11.1.6.3.3 Expansions
      • 11.1.6.4 MnM view
        • 11.1.6.4.1 Key strengths
        • 11.1.6.4.2 Strategic choices
        • 11.1.6.4.3 Weaknesses and competitive threats
    • 11.1.7 JOHNSON & JOHNSON MEDTECH
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Product launches and approvals
        • 11.1.7.3.2 Deals
      • 11.1.7.4 MnM view
        • 11.1.7.4.1 Key strengths
        • 11.1.7.4.2 Strategic choices
        • 11.1.7.4.3 Weaknesses and competitive threats
    • 11.1.8 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products offered
      • 11.1.8.3 Recent developments
        • 11.1.8.3.1 Product launches
        • 11.1.8.3.2 Deals
    • 11.1.9 EDWARDS LIFESCIENCES CORPORATION
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products offered
    • 11.1.10 CANON MEDICAL SYSTEMS CORPORATION
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products offered
      • 11.1.10.3 Recent developments
        • 11.1.10.3.1 Product launches
        • 11.1.10.3.2 Deals
    • 11.1.11 FUJIFILM HOLDINGS CORPORATION
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products offered
      • 11.1.11.3 Recent developments
        • 11.1.11.3.1 Product launches
        • 11.1.11.3.2 Deals
    • 11.1.12 GUERBET
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products offered
      • 11.1.12.3 Recent developments
        • 11.1.12.3.1 Deals
    • 11.1.13 TERUMO CORPORATION
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products offered
      • 11.1.13.3 Recent developments
        • 11.1.13.3.1 Deals
    • 11.1.14 LIVANOVA
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products offered
    • 11.1.15 INFRAREDX INC.
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products offered
    • 11.1.16 STEREOTAXIS, INC.
      • 11.1.16.1 Business overview
      • 11.1.16.2 Products offered
      • 11.1.16.3 Recent developments
        • 11.1.16.3.1 Deals
    • 11.1.17 B. BRAUN SE
      • 11.1.17.1 Business overview
      • 11.1.17.2 Products offered
    • 11.1.18 ESAOTE SPA
      • 11.1.18.1 Business overview
      • 11.1.18.2 Products offered
      • 11.1.18.3 Recent developments
        • 11.1.18.3.1 Product launches
  • 11.2 OTHER PLAYERS
    • 11.2.1 CHISON MEDICAL TECHNOLOGIES CO., LTD.
    • 11.2.2 SHIFAMED, LLC
    • 11.2.3 CONAVI MEDICAL INC.
    • 11.2.4 XUZHOU KAIXIN ELECTRONIC INSTRUMENT CO., LTD.
    • 11.2.5 BK MEDICAL
    • 11.2.6 BENQ MEDICAL TECHNOLOGY
    • 11.2.7 ECHONOUS INC.
    • 11.2.8 VOLTA MEDICAL
    • 11.2.9 TRIVITRON HEALTHCARE
    • 11.2.10 ECHOPIXEL
    • 11.2.11 CATHVISION
    • 11.2.12 PIE MEDICAL IMAGING BV

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 LIMITATIONS AND ASSOCIATED RISKS
  • TABLE 2 STUDIES ON AI IN ECHOCARDIOGRAPHIC DIAGNOSTICS
  • TABLE 3 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 US: CLASSIFICATION OF MEDICAL EQUIPMENT
  • TABLE 10 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 11 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 12 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 13 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 14 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES
  • TABLE 15 AVERAGE SELLING PRICE OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, BY REGION, 2023
  • TABLE 16 IMPORT DATA FOR INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES (HS CODE 901819), BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 17 EXPORT DATA FOR INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES (HS CODE 901819), BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 18 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS IN 2024-2025
  • TABLE 19 KEY REQUIREMENTS OF STAKEHOLDERS WHILE BUYING INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%)
  • TABLE 21 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: UNMET CUSTOMER NEEDS & KEY PAIN POINTS
  • TABLE 22 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 23 ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 24 ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 25 2D ULTRASOUND SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 26 3D/4D ULTRASOUND SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 27 DOPPLER ULTRASOUND SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 28 ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 29 ICE CATHETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 30 DOPPLER ICE CATHETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 31 PHASED-ARRAY ICE CATHETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 32 FIXED-ARRAY ICE CATHETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 33 MECHANICAL ROTATIONAL ICE CATHETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 34 ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 35 ICE CONSOLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 36 CART/TROLLEY-BASED CONSOLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 37 HANDHELD/PORTABLE CONSOLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 38 GUIDING CATHETERS & SHEATHS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 39 ICE DISPOSABLE ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 40 ICE SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 41 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 42 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 43 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 44 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR MITRAL VALVE REPAIR/REPLACEMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 45 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR AORTIC VALVE REPLACEMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 46 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR OTHER STRUCTURAL HEART DEFECTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 47 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR ELECTROPHYSIOLOGY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 48 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR LEFT ATRIAL APPENDAGE CLOSURE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 49 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR CARDIAC MONITORING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 50 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 51 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 52 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 53 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 54 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR HOSPITAL-BASED CATH LABS/HYBRID OR INTERVENTIONAL CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 55 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR INDEPENDENT DIAGNOSTIC CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 56 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 57 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 58 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 60 NORTH AMERICA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 61 NORTH AMERICA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 62 NORTH AMERICA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 63 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 64 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 66 US: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 67 US: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 68 US: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 69 US: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 70 CANADA: RESEARCH GRANTS IN INTRACARDIAC ECHOCARDIOGRAPHY
  • TABLE 71 CANADA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 72 CANADA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 73 CANADA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 74 CANADA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 75 EUROPE: PRODUCT APPROVALS IN INTRACARDIAC ECHOCARDIOGRAPHY
  • TABLE 76 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 77 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 78 EUROPE: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 79 EUROPE: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 80 EUROPE: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 81 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 82 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 83 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 84 GERMANY: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 85 GERMANY: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 86 GERMANY: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 87 GERMANY: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 88 UK: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 89 UK: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 90 UK: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 91 UK: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 92 FRANCE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 93 FRANCE: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 94 FRANCE: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 95 FRANCE: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 96 ITALY: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 97 ITALY: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 98 ITALY: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 99 ITALY: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 100 SPAIN: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 101 SPAIN: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 102 SPAIN: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 103 SPAIN: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 104 REST OF EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 105 REST OF EUROPE: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 106 REST OF EUROPE: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 107 REST OF EUROPE: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 108 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 111 ASIA PACIFIC: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 113 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 116 JAPAN: RECENT DEVELOPMENTS IN INTRACARDIAC ECHOCARDIOGRAPHY
  • TABLE 117 JAPAN: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 118 JAPAN: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 119 JAPAN: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 120 JAPAN: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 121 CHINA: RECENT DEVELOPMENTS IN INTRACARDIAC ECHOCARDIOGRAPHY
  • TABLE 122 CHINA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 123 CHINA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 124 CHINA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 125 CHINA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 126 INDIA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 127 INDIA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 128 INDIA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 129 INDIA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 130 AUSTRALIA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 131 AUSTRALIA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 132 AUSTRALIA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 133 AUSTRALIA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 134 SOUTH KOREA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 135 SOUTH KOREA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 136 SOUTH KOREA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 137 SOUTH KOREA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 138 REST OF ASIA PACIFIC: RECENT DEVELOPMENTS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET
  • TABLE 139 REST OF ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 140 REST OF ASIA PACIFIC: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 141 REST OF ASIA PACIFIC: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 142 REST OF ASIA PACIFIC: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 143 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 144 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 145 LATIN AMERICA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 146 LATIN AMERICA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 147 LATIN AMERICA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 148 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 149 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 150 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 151 BRAZIL: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 152 BRAZIL: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 153 BRAZIL: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 154 BRAZIL: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 155 MEXICO: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 156 MEXICO: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 157 MEXICO: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 158 MEXICO: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 159 REST OF LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 160 REST OF LATIN AMERICA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 161 REST OF LATIN AMERICA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 162 REST OF LATIN AMERICA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 163 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 164 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 165 MIDDLE EAST & AFRICA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 166 MIDDLE EAST & AFRICA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 167 MIDDLE EAST & AFRICA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 168 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 169 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 170 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 171 GCC COUNTRIES: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 172 GCC COUNTRIES: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 173 GCC COUNTRIES: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 174 GCC COUNTRIES: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 175 REST OF MIDDLE EAST & AFRICA (ROMEA): INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 176 REST OF MIDDLE EAST & AFRICA (ROMEA): ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 177 REST OF MIDDLE EAST & AFRICA (ROMEA): ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 178 REST OF MIDDLE EAST & AFRICA (ROMEA): ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET
  • TABLE 180 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: DEGREE OF COMPETITION
  • TABLE 181 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: PRODUCT FOOTPRINT
  • TABLE 182 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: APPLICATION FOOTPRINT
  • TABLE 183 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: END-USER FOOTPRINT
  • TABLE 184 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: REGION FOOTPRINT
  • TABLE 185 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 186 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 187 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-JUNE 2024
  • TABLE 188 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 189 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 190 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 191 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2020-JUNE 2024
  • TABLE 192 MEDTRONIC: DEALS, JANUARY 2020-JUNE 2024
  • TABLE 193 ABBOTT: COMPANY OVERVIEW
  • TABLE 194 ABBOTT: PRODUCTS OFFERED
  • TABLE 195 ABBOTT: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2020-JUNE 2024
  • TABLE 196 ABBOTT: DEALS, JANUARY 2020-JUNE 2024
  • TABLE 197 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 198 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
  • TABLE 199 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2020-JUNE 2024
  • TABLE 200 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 201 GE HEALTHCARE: PRODUCTS OFFERED
  • TABLE 202 GE HEALTHCARE: PRODUCT APPROVALS, JANUARY 2020-JUNE 2024
  • TABLE 203 GE HEALTHCARE: DEALS, JANUARY 2020-JUNE 2024
  • TABLE 204 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 205 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 206 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES, JANUARY 2020- JUNE 2024
  • TABLE 207 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2020-JUNE 2024
  • TABLE 208 BOSTON SCIENTIFIC CORPORATION: EXPANSIONS, JANUARY 2020-JUNE 2024
  • TABLE 209 PHILIPS HEALTHCARE: COMPANY OVERVIEW
  • TABLE 210 PHILIPS HEALTHCARE: PRODUCTS OFFERED
  • TABLE 211 PHILIPS HEALTHCARE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2020-JUNE 2024
  • TABLE 212 PHILIPS HEALTHCARE: DEALS, JANUARY 2020-JUNE 2024
  • TABLE 213 PHILIPS HEALTHCARE: EXPANSIONS, JANUARY 2020-JUNE 2024
  • TABLE 214 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW
  • TABLE 215 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED
  • TABLE 216 JOHNSON & JOHNSON MEDTECH: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2020-JUNE 2024
  • TABLE 217 JOHNSON & JOHNSON MEDTECH: DEALS, JANUARY 2020-JUNE 2024
  • TABLE 218 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
  • TABLE 219 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED
  • TABLE 220 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2020-JUNE 2024
  • TABLE 221 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: DEALS, JANUARY 2020-JUNE 2024
  • TABLE 222 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
  • TABLE 223 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED
  • TABLE 224 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
  • TABLE 225 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED
  • TABLE 226 CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES, JANUARY 2020-JUNE 2024
  • TABLE 227 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2020-JUNE 2024
  • TABLE 228 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 229 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
  • TABLE 230 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES, JANUARY 2020-JUNE 2024
  • TABLE 231 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2020-JUNE 2024
  • TABLE 232 GUERBET: COMPANY OVERVIEW
  • TABLE 233 GUERBET: PRODUCTS OFFERED
  • TABLE 234 GUERBET: DEALS, JANUARY 2020-JUNE 2024
  • TABLE 235 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 236 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 237 TERUMO CORPORATION: DEALS, JANUARY 2020-JUNE 2024
  • TABLE 238 LIVANOVA: COMPANY OVERVIEW
  • TABLE 239 LIVANOVA: PRODUCTS OFFERED
  • TABLE 240 INFRAREDX INC.: COMPANY OVERVIEW
  • TABLE 241 INFRAREDX INC.: PRODUCTS OFFERED
  • TABLE 242 STEREOTAXIS, INC.: COMPANY OVERVIEW
  • TABLE 243 STEREOTAXIS, INC.: PRODUCTS OFFERED
  • TABLE 244 STEREOTAXIS, INC.: DEALS, JANUARY 2020-JUNE 2024
  • TABLE 245 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 246 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 247 ESAOTE SPA: COMPANY OVERVIEW
  • TABLE 248 ESAOTE SPA: PRODUCTS OFFERED
  • TABLE 249 ESAOTE SPA: PRODUCT LAUNCHES, JANUARY 2020-JUNE 2024
  • TABLE 250 CHISON MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
  • TABLE 251 SHIFAMED, LLC: COMPANY OVERVIEW
  • TABLE 252 CONAVI MEDICAL INC.: COMPANY OVERVIEW
  • TABLE 253 XUZHOU KAIXIN ELECTRONIC INSTRUMENT CO., LTD.: COMPANY OVERVIEW
  • TABLE 254 BK MEDICAL: COMPANY OVERVIEW
  • TABLE 255 BENQ MEDICAL TECHNOLOGY: COMPANY OVERVIEW
  • TABLE 256 ECHONOUS INC.: COMPANY OVERVIEW
  • TABLE 257 VOLTA MEDICAL: COMPANY OVERVIEW
  • TABLE 258 TRIVITRON HEALTHCARE: COMPANY OVERVIEW
  • TABLE 259 ECHOPIXEL: COMPANY OVERVIEW
  • TABLE 260 CATHVISION: COMPANY OVERVIEW
  • TABLE 261 PIE MEDICAL IMAGING BV: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
  • FIGURE 5 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 6 TOP-DOWN APPROACH
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • FIGURE 8 GROWTH PROJECTIONS WERE BASED ON REVENUE IMPACT OF KEY MACROINDICATORS
  • FIGURE 9 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 10 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 GEOGRAPHICAL SNAPSHOT OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET
  • FIGURE 13 INCREASING DEMAND FOR PREDICTIVE ANALYTICS IN ICE DEVICES-MAJOR FACTOR DRIVING INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET
  • FIGURE 14 ASIA PACIFIC REGIONAL MARKET TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 15 HOSPITALS & SURGICAL CENTERS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 16 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 17 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: PORTER'S FIVE FORCES MODEL
  • FIGURE 19 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 20 NUMBER OF DEALS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, 2018-2022 (USD MILLION)
  • FIGURE 21 NUMBER OF INVESTOR DEALS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY KEY PLAYER, 2018-2022
  • FIGURE 22 VALUE OF INVESTOR DEALS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY KEY PLAYER, 2018-2022 (USD MILLION)
  • FIGURE 23 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 24 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 25 AVERAGE SELLING PRICE OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, BY PRODUCT (USD THOUSAND)
  • FIGURE 26 AVERAGE SELLING PRICE TREND OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, BY KEY PLAYER, 2021-2023 (USD)
  • FIGURE 27 AVERAGE SELLING PRICE TREND OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, BY REGION, 2021-2023 (USD)
  • FIGURE 28 PATENT DETAILS FOR INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, JANUARY 2013-DECEMBER 2023
  • FIGURE 29 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
  • FIGURE 30 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: BUYING CRITERIA
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES
  • FIGURE 32 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SNAPSHOT
  • FIGURE 33 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SNAPSHOT
  • FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET (2019-2023)
  • FIGURE 35 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SHARE ANALYSIS (2023)
  • FIGURE 36 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS)
  • FIGURE 37 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: COMPANY FOOTPRINT
  • FIGURE 38 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 39 EV/EBITDA OF KEY VENDORS
  • FIGURE 40 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 41 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 42 MEDTRONIC: COMPANY SNAPSHOT (2023)
  • FIGURE 43 ABBOTT: COMPANY SNAPSHOT (2023)
  • FIGURE 44 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
  • FIGURE 45 GE HEALTHCARE: COMPANY SNAPSHOT (2023)
  • FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 47 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2023)
  • FIGURE 48 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2023)
  • FIGURE 49 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 50 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 51 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 52 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 53 GUERBET: COMPANY SNAPSHOT (2023)
  • FIGURE 54 TERUMO CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 55 LIVANOVA: COMPANY SNAPSHOT (2022)
  • FIGURE 56 STEREOTAXIS, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 57 B. BRAUN SE: COMPANY SNAPSHOT (2023)